Zeitraum:
Zeichenmodus:
| Volumen | 17.340.917 |
|
|||||
| News | (3) |
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd | TEVA | NYSE | Depository Receipt |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,06 | 0,81% | 7,44 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 7,51 | 7,37 | 7,645 | 7,39 | 7,38 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen |
|---|---|---|---|---|
| 48.613 | 17.340.917 | 7,47 | 129.592.538 | - |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:59:23 | 14 | 7,44 | USD |
Finanzwerte TEVA
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 8,33B | 1,12B | 1,11B | 3,66B | -2,56M | -0,18 | -3.251,57 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | 756,02k | 0,10% |
News Teva Pharmaceutical Indu...
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 08.6.2023 | 15:27 | Dow Jones News | Teva Pharma Reaches Opioid Settlement With Nevada, the Final.. |
| 08.6.2023 | 14:31 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 08.6.2023 | 14:30 | Business Wire | Teva Concludes Nationwide Opioids Settlement Agreement |
| 06.6.2023 | 14:00 | Business Wire | Phil and Teva Pharmaceuticals Launch New Program to Improve.. |
| 02.6.2023 | 22:30 | Business Wire | Teva Presents Real-World Data for AUSTEDO®.. |
| 24.5.2023 | 22:29 | Edgar (US Regulatory) | Specialized Disclosure Report (sd) |
| 24.5.2023 | 22:16 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) |
| 20.5.2023 | 17:00 | Business Wire | Teva to Present Data Demonstrating UZEDY™ (risperidone).. |
| 18.5.2023 | 14:30 | Business Wire | Teva Launches New “Pivot to Growth” Strategy |
| 15.5.2023 | 14:00 | Business Wire | AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, New.. |
| 11.5.2023 | 22:01 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10.5.2023 | 22:05 | Edgar (US Regulatory) | Quarterly Report (10-q) |
Forum Teva Pharmaceutical Indu...
Keine Diskussionen Gefunden.Neuen Thread Erstellen
TEVA Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,0% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,0% |
| 3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,0% |
| 6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,0% |
| 1 Jahr | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,0% |
| 3 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,0% |
| 5 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,0% |